Measuring Acute Drug Demand in Humans
University of Maryland, Baltimore · with National Institute on Drug Abuse (NIDA) · NCT05829655
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 75
- US sites recruiting
- 1
- Study start
- August 8, 2023
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This research is being done to evaluate whether suvorexant may reduce the use of, subjective liking, and demand for various drugs.
Being studied: Drug A (Blinded Drug); Drug B (Blinded Drug); Drug C (Blinded Drug); Drug D (Blinded Drug); Suvorexant (20mg/day); Placebo
Conditions: Opioid Use Disorder; Opioid Dependence
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age between 18 and 65 years old
- Meets Diagnostic and Statistical Manual-5 criteria for Opioid Use Disorder (OUD) (moderate or severe)
- Lifetime substance use history criterion [blinded]
- Medically cleared to take suvorexant and blinded study medications
- Be in good general health based on a physical examination, medical history, vital signs, and screening urine and blood tests
Exclusion Criteria
- Pregnant or breast feeding
- Seeking opioid use treatment
- Significant mental health or physical disorder that is expected to interfere with study participation as assessed by the study physicians or medical staff
- Known contraindications or allergies to suvorexant and/or the blinded study medications
Recruiting US locations
General Clinical Research Center
Baltimore, MD 21201
Site contact: Justin Strickland, PhD · 667-354-3516 · jstrickland@som.umaryland.edu
Study contacts (from the official record)
- Justin Strickland, PhD · 667-354-3516 · jstrickland@som.umaryland.edu
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55